Blood Gas and Electrolyte Analyzer Market by Type [Analyzers/Instruments by Product Type (Blood Gas Analyzers, Electrolyte Analyzers, and Combined Analyzers), and Modality (Portable, Benchtop, and Laboratory) and Consumables], Product/Brand (i-STAT,

"Market Definition:
The Global Blood Gas and Electrolyte Analyzer Market was valued at USD 3.57 Billion in 2019 and is projected to reach USD 6.24 Billion by 2030, expanding at a CAGR of 5.2%, during the forecast period, from 2020 to 2030.
A blood gas and electrolyte analyzer is used to measure electrolytes, blood gas, and metabolites in a blood specimen. The analyzer is used to highlight abnormal electrolyte levels in the blood, levels of oxygen/carbon dioxide exchange, and a patient's acid-base balance. The pH values of the sample indicate to the balance or imbalance between the renal (kidney), blood, and lung (respiratory) systems.
Market Dynamics and Trends
Growth in geriatric population and the surge in the number of patients in hospitals for receiving critical care, are driving the blood gas and electrolyte analyzer market. Also, burgeoning population base is expected to boost the use of blood gas and electrolyte analyzers. Moreover, implementation of technologically advanced devices and the launch of newly approved products are estimated to propel the market growth. However, complexities in blood analysis data interpretation may hamper the market. On the other hand, increasing investments and growth of the healthcare industry are expected to create lucrative opportunities in the market.
Market Segmentations and Scope of the Study:
The global blood gas and electrolyte analyzer market is segmented on the basis of type, product/brand, end user, and geography. Based on type, the market is segmented into analyzers/instruments and consumables. The analyzers/instruments segment is divided into product type and modality. The product type sub-segment is classified as blood gas analyzers, electrolyte analyzers, and combined analyzers. The modality sub-segment is categorized as portable, benchtop, and laboratory. In terms of product/brand, the market is segregated intoi-STAT, GEM premier, ABL flex, RAPID series, Cobas, and others. Based on end user, the market is segregated into hospitals, clinics, ambulatory surgical centers, and others. On the basis of geography, the market is fragmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Geographical Analysis
North America holds the major share of the global blood gas and electrolyte analyzer market due to the presence of an advanced healthcare industry and increasing number of patients requiring treatments in the ICUs, NICUs, and emergency wards.
The market of Asia-Pacific is expected to grow at a high pace owing to rising investments by governments in healthcare infrastructure and surge in the number of patients suffering from chronic diseases.

Competitive Landscape

Key players in the global Blood Gas and Electrolyte Analyzer Market include Radiometer Medical Aps (A Subsidiary of Danaher Corporation), Instrumentation Laboratory (A Werfen Company), Siemens AG, Roche Diagnostics Limited, Abbott Laboratories, Inc., Nova Biomedical, OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.), ERBA Diagnostics Mannheim GmbH, Medica Corporation, and Alere, Inc.
In March 2020, the U.S.FDA approved Siemens Healthineers’s critical care testing solution, the RAPIDPoint 500e blood gas analyzer. In May 2020, Rochehad announced that it received the CE mark for Roche v-TAC, a digital diagnostic solution that allows clinicians obtain results for arterial blood gas values of patients with respiratory or metabolic abnormalities. The Roche v-TAC is simple to use and is less invasive using a digital algorithm.
KEY MARKET SEGMENTS:
• Global Blood Gas and Electrolyte Analyzer Market –

By Type

o Analyzers/Instruments
 Product Type
• Blood Gas Analyzers
• Electrolyte Analyzers
• Combined Analyzers
 Modality
• Portable
• Benchtop
• Laboratory
o Consumables
• Global Blood Gas and Electrolyte Analyzer Market – By Product/Brand
o i-Stat (Abbott Laboratories)
o GEM Premier (Instrumentation Laboratory)
o ABL Flex (Radiometer)
o Cobas (Roche Diagnostics)
o RAPID Series (Siemens Healthineers)
o Others
• Global Blood Gas and Electrolyte Analyzer Market – By End User
o Hospitals
o Clinics
o Ambulatory Surgical Centers (ASC)
o Others
• Global Blood Gas and Electrolyte Analyzer Market – By Geography
o North America
 U.S.
 Canada
 Mexico
o Europe
 UK
 France
 Germany
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Rest of Asia-Pacific
o RoW
 Latin America
 Middle East
 Africa
KEY PLAYERS:
• Radiometer Medical Aps (A Subsidiary of Danaher Corporation)
• Instrumentation Laboratory (A Werfen Company)
• Siemens AG
• Roche Diagnostics Limited
• Abbott Laboratories, Inc.
• Nova Biomedical
• OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.)
• ERBA Diagnostics Mannheim GmbH
• Medica Corporation
• Alere, Inc."